HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application

BACKGROUND: Gliflozins and gliptins are two distinct groups of pharmacological drugs that reduce blood glucose levels in individuals with type II diabetes in various ways that may perform their functions harmoniously. Trijardy(®) tablet, which contains empagliflozin, linagliptin, and metformin, was...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahgat, Eman A., Hashem, Hisham, Saleh, Hanaa, Kamel, Ebraam B., Eissa, Maya S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018879/
https://www.ncbi.nlm.nih.gov/pubmed/36922860
http://dx.doi.org/10.1186/s13065-023-00927-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018879/
https://www.ncbi.nlm.nih.gov/pubmed/36922860
http://dx.doi.org/10.1186/s13065-023-00927-0

Ejemplares similares